Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients

doi:10.4253/wjge.v17.i3.99540

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=0

Mar 16, 2025 (publication date) through Mar 14, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Endosc. Mar 16, 2025; 17(3): 99540
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.99540

Table 1 A comparison between baseline and clinicopathological characteristics of elderly patients in different groups, n (%)

Characteristics	Number (n = 653)	Non-MGC (n = 607)	MGC (n = 46)	P value
Age, years (IQR)	70 (67-74)	70 (67-74)	69 (67-73)	0.186
Sex				0.354
Male	465 (71.2)	429 (70.7)	36 (78.3)
Female	188 (28.8)	178 (29.3)	10 (21.7)
Tobacco abuse	225 (34.5)	205 (33.8)	20 (43.5)	0.240
Alcohol abuse	180 (27.6)	166 (27.3)	14 (30.4)	0.779
Family history of cancer	101 (15.5)	92 (15.2)	9 (19.6)	0.558
MASLD	63 (9.7)	53 (8.73)	10 (21.7)	0.008
Hypertension	202 (30.9)	185 (30.5)	17 (37.0)	0.453
Diabetes	68 (10.4)	62 (10.2)	6 (13.0)	0.614
Cardiovascular disease	55 (8.4)	52 (8.6)	3 (6.5)	0.837
Cerebrovascular disease	43 (6.6)	37 (6.1)	6 (13.0)	0.111
H. pylori infection				< 0.001
Negative	99 (15.2)	95 (15.7)	4 (8.70)
Eradicated	508 (77.8)	481 (79.2)	27 (58.7)
Persistent	46 (7.0)	31 (5.1)	15 (32.6)
Baseline atrophy				0.031
Mild/moderate (C0-C3)	479 (73.4)	452 (74.5)	27 (58.7)
Severe (O1-O3)	174 (26.6)	155 (25.5)	19 (41.3)
Location				0.593
Cardia	323 (49.5)	298 (49.1)	25 (54.3)
Non-cardia	330 (50.5)	309 (50.9)	21 (45.7)
Macroscopic shape				0.034
Elavated (I, IIa)	220 (33.7)	206 (33.9)	14 (30.4)
Flated (IIb)	180 (27.6)	160 (26.4)	20 (43.5)
Depressed (IIc, III)	253 (38.7)	241 (39.7)	12 (26.1)
Tumor size, cm				0.614
< 2	371 (56.8)	347 (57.2)	24 (52.2)
≥ 2	282 (43.2)	260 (42.8)	22 (47.8)
Depth of invasion				1
Mucosa	488 (74.7)	454 (74.8)	34 (73.9)
Submucosa	165 (25.3)	153 (25.2)	12 (26.1)
Differentiation				0.047
WD/MD	581 (89.0)	536 (88.3)	45 (97.8)
PD	72 (11.0)	71 (11.7)	1 (2.2)
Ulceration	46 (7.0)	41 (6.8)	5 (10.9)	0.452
Initial multifocality	121 (18.5)	107 (17.6)	14 (30.4)	0.050
Median follow-up time, months	38 (25-55)	38 (26-56)	29 (19-45)	0.001

C: Closed; MASLD: Metabolic dysfunction-associated steatotic liver disease; MD: Moderately differentiated; O: Open; PD: Poorly differentiated; WD: Well-differentiated; H. pylori: Helicobacter pylori; MGC: Metachronous gastric cancer.

Citation: Xiang Y, Yuan Y, Wang ZY, Zhu YM, Li WY, Ye QG, Wang YN, Sun Q, Ding XW, Longi F, Tang DH, Xu GF. Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients. World J Gastrointest Endosc 2025; 17(3): 99540
URL: https://www.wjgnet.com/1948-5190/full/v17/i3/99540.htm
DOI: https://dx.doi.org/10.4253/wjge.v17.i3.99540